On the basis of the TCGA BC pathological slides data, we found that TP53-mutated BCs had markedly higher percentages of lymphocyte infiltration compared to TP53-wildtype BCs (Mann-Whitney U test, P=0.01) (Figure 1(c)). Here, TP53 is linked to breast cancer.